Indeed, PCa is labeled as a “cold tumor”, and is characterized by the low presence of neoantigens, reduced MHC expression, limited infiltration of T cells, and low responsiveness to immunotherapy [7,8,9]. This evidence concerns the gene HLA-C and posterior cortical atrophy.